Alpha Crest Capital Management LLC Reata Pharmaceuticals Inc Transaction History

Alpha Crest Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$24.12 - $39.6 $1.75 Million - $2.87 Million	-72,489 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$25.61 - $110.96 $1.73 Million - $7.49 Million	67,508 Added 1355.31%	72,489 $1.91 Million
Q3 2021 Nov 10, 2021	BUY	$100.0 - $143.02 $6,900 - $9,868	69 Added 1.4%	4,981 $501,000
Q2 2021 Aug 12, 2021	SELL	$78.27 - $151.29 $351,275 - $678,989	-4,488 Reduced 47.74%	4,912 $695,000
Q1 2021 May 13, 2021	BUY	$94.25 - $132.81 $725,725 - $1.02 Million	7,700 Added 452.94%	9,400 $937,000
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $173,451 - $313,854	1,700 New	1,700 $210,000
Q2 2020 Aug 12, 2020	SELL	$126.3 - $176.56 $315,750 - $441,400	-2,500 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$124.16 - $247.74 $310,400 - $619,350	2,500 New	2,500 $361,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.